| AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial PA LeWitt, AR Rezai, MA Leehey, SG Ojemann, AW Flaherty, ... The Lancet Neurology 10 (4), 309-319, 2011 | 790 | 2011 |
| Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma S Kunwar, S Chang, M Westphal, M Vogelbaum, J Sampson, G Barnett, ... Neuro-oncology 12 (8), 871-881, 2010 | 540 | 2010 |
| A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant … EA Chiocca, KM Abbed, S Tatter, DN Louis, FH Hochberg, F Barker, ... Molecular Therapy 10 (5), 958-966, 2004 | 534 | 2004 |
| Predictors of successful extubation in neurosurgical patients AM Namen, E Wesley Ely, SB Tatter, L Douglas Case, MA Lucia, A Smith, ... American journal of respiratory and critical care medicine 163 (3), 658-664, 2001 | 456 | 2001 |
| Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man. Y Fong, LL Moldawer, M Marano, H Wei, SB Tatter, RH Clarick, ... Journal of immunology (Baltimore, Md.: 1950) 142 (7), 2321-2324, 1989 | 424 | 1989 |
| Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. LT May, J Ghrayeb, U Santhanam, SB Tatter, Z Sthoeger, DC Helfgott, ... Journal of Biological Chemistry 263 (16), 7760-7766, 1988 | 369 | 1988 |
| Activation of the human" beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists. A Ray, SB Tatter, LT May, PB Sehgal Proceedings of the National Academy of Sciences 85 (18), 6701-6705, 1988 | 295 | 1988 |
| Poor drug distribution as a possible explanation for the results of the PRECISE trial JH Sampson, G Archer, C Pedain, E Wembacher-Schröder, M Westphal, ... Journal of neurosurgery 113 (2), 301-309, 2010 | 293 | 2010 |
| Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. DC Helfgott, SB Tatter, U Santhanam, RH Clarick, N Bhardwaj, LT May, ... Journal of immunology (Baltimore, Md.: 1950) 142 (3), 948-953, 1989 | 285 | 1989 |
| Convection-enhanced delivery for the treatment of brain tumors W Debinski, SB Tatter Expert review of neurotherapeutics 9 (10), 1519-1527, 2009 | 239 | 2009 |
| Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward KT Kishida, I Saez, T Lohrenz, MR Witcher, AW Laxton, SB Tatter, ... Proceedings of the National Academy of Sciences 113 (1), 200-205, 2016 | 236 | 2016 |
| The role of laser interstitial thermal therapy in enhancing progression‐free survival of difficult‐to‐access high‐grade gliomas: a multicenter study AM Mohammadi, AH Hawasli, A Rodriguez, JL Schroeder, AW Laxton, ... Cancer medicine 3 (4), 971-979, 2014 | 229 | 2014 |
| Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies Y Li, R Rey-Dios, DW Roberts, PA Valdés, AA Cohen-Gadol World neurosurgery 82 (1-2), 175-185, 2014 | 202 | 2014 |
| Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis M Ahluwalia, GH Barnett, D Deng, SB Tatter, AW Laxton, AM Mohammadi, ... Journal of neurosurgery 130 (3), 804-811, 2018 | 188 | 2018 |
| Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis CA Jensen, MD Chan, TP McCoy, JD Bourland, AF DeGuzman, TL Ellis, ... Journal of neurosurgery 114 (6), 1585-1591, 2011 | 181 | 2011 |
| Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease DT Brocker, BD Swan, DA Turner, RE Gross, SB Tatter, MM Koop, ... Experimental neurology 239, 60-67, 2013 | 177 | 2013 |
| Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus … PB Sehgal, DC Helfgott, U Santhanam, SB Tatter, RH Clarick, J Ghrayeb, ... The Journal of experimental medicine 167 (6), 1951-1956, 1988 | 177 | 1988 |
| Immersion bioprinting of tumor organoids in multi-well plates for increasing chemotherapy screening throughput E Maloney, C Clark, H Sivakumar, KM Yoo, J Aleman, SAP Rajan, ... Micromachines 11 (2), 208, 2020 | 153 | 2020 |
| GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis AJ Gabayan, SB Green, A Sanan, J Jenrette, C Schultz, M Papagikos, ... Neurosurgery 58 (4), 701, 2006 | 152 | 2006 |
| Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation LT May, G Torcia, F Cozzolino, A Ray, SB Tatter, U Santhanam, ... Biochemical and biophysical research communications 159 (3), 991-998, 1989 | 149 | 1989 |
Michael D. Chan, M.D.Professor of Radiation Oncologyایمیل تأیید شده در wakehealth.edu
